WallStreetZenWallStreetZen

NASDAQ: OMGA
Omega Therapeutics Inc Stock Ownership - Who owns Omega Therapeutics?

Insider buying vs selling

Have Omega Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Richard A. YoungDirector2023-06-025,000$8.00
$40.00kSell
Richard A. YoungDirector2023-05-015,000$8.00
$40.00kSell
Richard A. YoungDirector2023-04-065,000$8.00
$40.00kSell

1 of 1

OMGA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OMGA insiders and whales buy or sell their stock.

OMGA Shareholders

What type of owners hold Omega Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Flagship Pioneering Inc56.99%31,422,638$106.52MInsider
Flagship Pioneering Inc53.00%29,225,579$99.07MInstitution
Fmr LLC9.59%5,286,575$17.92MInstitution
Harbourvest Partners LLC6.37%3,512,110$11.91MInstitution
Invus Public Equities LP4.12%2,273,530$7.71MInsider
State Of Wisconsin Investment Board3.37%1,857,265$6.30MInstitution
Vanguard Group Inc2.74%1,509,188$5.12MInstitution
Blackrock Inc2.51%1,382,280$4.69MInstitution
Flagship Pioneering Fund Vii General Partner LLC2.41%1,329,324$4.51MInsider
Artal Group Sa2.40%1,323,530$4.49MInstitution

1 of 3

OMGA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OMGA57.75%42.25%Net Selling
AMLX52.71%47.29%Net BuyingNet Selling
RPTX61.14%38.86%Net BuyingNet Selling
PRQR22.61%0.00%
IPHA0.16%0.00%

Omega Therapeutics Stock Ownership FAQ

Who owns Omega Therapeutics?

Omega Therapeutics (NASDAQ: OMGA) is owned by 91.10% institutional shareholders, 66.65% Omega Therapeutics insiders, and 0.00% retail investors. Flagship Pioneering Inc is the largest individual Omega Therapeutics shareholder, owning 31.42M shares representing 56.99% of the company. Flagship Pioneering Inc's Omega Therapeutics shares are currently valued at $111.55M.

If you're new to stock investing, here's how to buy Omega Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.